MetaCap

Sonoma Pharmaceuticals (SNOA) vs Tenon Medical (TNON)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Sonoma Pharmaceuticals is the larger company by market cap ($3.7 million vs $2.4 million), about 1.5 times the size. Sonoma Pharmaceuticals converts more of its revenue into profit, with a net margin of -16.3% versus -318.4%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SNOA-40.82%TNON-74.37%
+5%-36%-78%
Oct 7, 20261 yearNov 20, 2026
SNOA-41.30%TNON-73.69%
+4%-37%-77%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SNOA versus TNON key metrics
MetricSNOATNON
Share price$0.722$0.8972
Market cap$3.65M$2.41M
1-day change-10.83%-8.97%
YTD return—-97.31%
1-year return—-97.67%
EPS (TTM)$-0.90$-30.18
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$19.53M$3.94M
Revenue growth (YoY)+36.68%+20.35%
Net income (latest FY)$-3.17M$-12.56M
Gross margin37.97%59.79%
Operating margin-12.60%-324.34%
Net margin-16.26%-318.36%
52-week high$3.95$40.95
52-week low$0.72$0.886
Distance from 52-week high-81.72%-97.81%
Analyst consensus—none
Avg. price target upside—+4846.50%
Average volume61.96K5.46M
Shares outstanding5.06M2.68M
Employees1026
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Sonoma Pharmaceuticals is more profitable, keeping -16.3 cents of every revenue dollar as net income versus -318.4 cents for Tenon Medical.
  • Sonoma Pharmaceuticals grew revenue faster in its latest fiscal year (+36.68% vs +20.35%).

About Sonoma Pharmaceuticals

SNOA stock →

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.

Health Care · Medical/Dental Instruments · 10 employees

About Tenon Medical

TNON stock →

Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain.

Health Care · Medical/Dental Instruments · 26 employees

SNOA vs TNON FAQ

Which is bigger, Sonoma Pharmaceuticals or Tenon Medical?

Sonoma Pharmaceuticals (SNOA) is larger, with a market capitalization of $3.65M compared with $2.41M for Tenon Medical (TNON).

Are Sonoma Pharmaceuticals and Tenon Medical in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons